Expansion of the CHN1 strabismus phenotype

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 9, 2011, Pages 6321-6328

  Miyake, Noriko ^a,b   Demer, Joseph L ^c,d,e,f   Shaaban, Sherin ^a,g,h   Andrews, Caroline ^a,g,i   Chan, Wai Man ^a,i   Christiansen, Stephen P ^j   Hunter, David G ^a,g   Engle, Elizabeth C ^a,g,i  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Engineering IV   (United States)

^f JULES STEIN EYE INSTITUTE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h MANSOURA UNIVERSITY   (Egypt)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIN; PHENYLALANINE; RAC PROTEIN; TYROSINE;

ABDUCENS NERVE; AMINO ACID SUBSTITUTION; ARTICLE; CHN1 GENE; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 2Q; CONTROLLED STUDY; DUANE RETRACTION SYNDROME; FEMALE; GENE; GENE MUTATION; GENE TRANSLOCATION; HAPLOTYPE; HUMAN; HUMAN CELL; LINKAGE ANALYSIS; MALE; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOMOTOR NERVE; OPTIC NERVE; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; STRABISMUS; SUPERIOR OBLIQUE MUSCLE; TROCHLEAR NERVE; CHROMOSOME 2; CONGENITAL MALFORMATION; CRANIAL NEUROPATHY; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETICS; METABOLISM; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OPHTHALMIC NERVE; PEDIGREE; PHYSIOLOGY;

ABDUCENS NERVE; AMINO ACID SUBSTITUTION; CHIMERIN 1; CHROMOSOMES, HUMAN, PAIR 2; CRANIAL NERVE DISEASES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC LINKAGE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION, MISSENSE; OPHTHALMIC NERVE; OPTIC NERVE; PEDIGREE; PHENOTYPE; RAC GTP-BINDING PROTEINS; STRABISMUS;

EID: 80053517384     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7950     Document Type: Article

References (23)

1. Engle EC. Human genetic disorders of axon guidance. Cold Spring Harb Perspect Biol. 2:a001784, 2010.
2. Oystreck DT, Engle EC, Bosley TM. Recent progress in understanding congenital cranial dysinnervation disorders. J Neuroophthalmol. 2011;31:69-77.
3. Yamada K, Andrews C, Chan WM, et al. Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat Genet. 2003;35:318-321.
4. Tischfield MA, Baris HN, Wu C, et al. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell. 2010;140:74-87.
5. Nakano M, Yamada K, Fain J, et al. Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2. Nat Genet. 2001;29:315-320.
6. Al-Baradie R, Yamada K, St Hilaire C, et al. Duane radial ray syndrome (Okihiro Syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet. 2002;71:1195-1199.
7. Tischfield MA, Bosley TM, Salih MA, et al. Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nat Genet. 2005;37:1035-1037.
8. Jen JC, Chan WM, Bosley TM, et al. Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science. 2004;304:1509-1513.
9. Miyake N, Chilton J, Psatha M, et al. Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome. Science. 2008;321:839-843.
10. Chan WM, Miyake N, Zhu-Tam L, Andrews C, Engle EC. Two novel CHN1 mutations in two families with Duane's retraction syndrome. Arch Ophthalmol. 2011;129:649-652.
11. Dong JM, Smith P, Hall C, Lim L. Promoter region of the transcriptional unit for human alpha 1-chimaerin, a neuron-specific GTPaseactivating protein for p21rac. Eur J Biochem. 1995;227:636-646.
12. Chung M, Stout JT, Borchert MS. Clinical diversity of hereditary Duane's retraction syndrome. Ophthalmology. 2000;107:500-503.
13. Engle EC, Andrews C, Law K, Demer JL. Two pedigrees segregating Duane's retraction syndrome as a dominant trait map to the DURS2 genetic locus. Invest Ophthalmol Vis Sci. 2007;48:189-193.
14. Demer JL, Clark RA, Lim KH, Engle EC. Magnetic resonance imaging evidence for widespread orbital dysinnervation in dominant Duane's retraction syndrome linked to the DURS2 locus. Invest Ophthalmol Vis Sci. 2007;48:194-202.
15. Demer JL, Ortube MC, Engle EC, Thacker N. High-resolution magnetic resonance imaging demonstrates abnormalities of motor nerves and extraocular muscles in patients with neuropathic strabismus. J AAPOS. 2006;10:135-142.
16. Canagarajah B, Leskow FC, Ho, J.Y. et al. Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin. Cell. 2004;119:407-418.
17. Kozma R, Ahmed S, Best A, Lim L. The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia. Mol Cell Biol. 1996;16: 5069-5080.
18. Park HJ, Hampp C, Demer JL. Longitudinal study of optic cup progression in children. J Pediatr Ophthalmol Strabismus. 2011; 48:151-156.
19. Brown M, Jacobs T, Eickholt B, et al. Alpha2-chimaerin, cyclindependent kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse. J Neurosci. 2004;24:8994-9004.
20. Iwasato T, Katoh H, Nishimaru H, et al. Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of ephrinB3/ ephA4 forward signaling. Cell. 2007;130:742-753.
21. Shi L, Fu WY, Hung KW, et al. Alpha2-chimaerin interacts with ephA4 and regulates ephA4-dependent growth cone collapse. Proc Natl Acad Sci U S A. 2007;104:16347-16352.
22. Demer JL, Clark RA, Engle EC. Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A. Invest Ophthalmol Vis Sci. 2005;46:530-539.
23. Demer JL, Clark R, Tischfield MA, Engle EC. Evidence of an asymmetrical endophenotype in congenital fibrosis of extraocular muscles type 3 resulting from TUBB3 mutations. Invest Ophthalmol Vis Sci. 2010;51:4600-4611.